By addressing the two major failure points of standard GLP-1 treatment rapid, inflexible titration and lack of lifestyle intervention Noom aims to maximize long-term adherence and health benefits
Johansen P, Hunt B, Iyer NN, Dang-Tan T, Pollock RF
Plan selection during the next Annual Enrollment Period will be critical if you want continued GLP-1 access
Mar 28, 2023 Fair Square Bulletin: We're Revolutionizing Medicare Apr 27, 2023 Does Medicare Cover Cardiac Ablation
It is thought that this medication may negatively impact existing eating disorders (or the risk of development of an eating disorder in high-risk individuals) by the actual desired/ anticipated effect of the drug: increased feeling of satiety and decreased hunger sensation
Second, the respective study populations were quite different, with STEP 1 including a younger, healthier population with more women (73.1% of the semaglutide arm in STEP 1 versus 27.7% in SELECT) and higher mean BMI (37.8 kg m 2 versus 33.3 kg m 2 , respectively) 14,21